Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 5,028 | 4,400 | 6,876 | 7,349 | 7,915 |
Operating Income | -5,028 | -4,400 | -6,876 | -7,349 | -7,915 |
Other Income | 5 | 10 | 128 | 114 | 166 |
Pre-tax Income | -5,023 | -4,390 | -6,748 | -7,235 | -7,749 |
Net Income Continuous | -5,023 | -4,390 | -6,748 | -7,235 | -7,749 |
Net Income | $-5,023 | $-4,390 | $-6,748 | $-7,235 | $-7,749 |
EPS Basic Total Ops | -2.60 | -2.80 | -4.80 | -3.40 | -5.60 |
EPS Basic Continuous Ops | -2.55 | -2.81 | -4.85 | -3.42 | -5.57 |
EPS Diluted Total Ops | -2.60 | -2.80 | -4.80 | -3.40 | -5.60 |
EPS Diluted Continuous Ops | -2.55 | -2.81 | -4.85 | -3.42 | -5.57 |
EBITDA(a) | $-4,997 | $-4,337 | $-6,836 | $-7,335 | $-7,969 |